Brimonidine Tartrate
Pricing Report NDC 60758-866-05

Latest NADAC: $0.73110 per ML · Effective Nov 23, 2016 · Est. package price $3.66 (5 ML)

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Brimonidine Tartrate (NDC 60758-866-05) is $0.73110 per ML. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Nov 23, 2016.

As a provided by Pacific Pharma, Inc., this medication is distributed in a 1 BOTTLE, DROPPER in 1 CARTON / 5 mL in 1 BOTTLE, DROPPER configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.73110
Per ML

Effective Date
Nov 23, 2016
Billable Units
5 ML
Estimated Package Price
$3.66
Data Status
As of Dec 14, 2016
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 BOTTLE, DROPPER in 1 CARTON / 5 mL in 1 BOTTLE, DROPPER
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.60727 to $1.04712 per ML. Over this 4 years period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.6073 - $0.9313
Market Volatility
53.36% Variance
Latest Trend
6.69%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Dec 20, 2017 $0.64792 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Nov 22, 2017 $0.60727 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Oct 18, 2017 $0.63405 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Sep 20, 2017 $0.66058 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Aug 23, 2017 $0.87697 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jul 19, 2017 $0.83932 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jun 21, 2017 $0.76475 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
May 17, 2017 $0.73151 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Apr 19, 2017 $0.70940 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Mar 22, 2017 $0.71585 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Feb 22, 2017 $0.66436 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jan 18, 2017 $0.75592 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026